共 38 条
- [21] Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease JOURNAL OF CROHNS & COLITIS, 2019, 13 : S420 - S420
- [22] Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19? Digestive Diseases and Sciences, 2021, 66 : 2855 - 2864